Report DescriptionAbout IMARC Group

The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Global Cholera Vaccines Market Research Report:

The latest report by IMARC, titled “ Cholera Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023 -2028

” " the global cholera vaccines market reached a value of US$ 4.9 Million in 2022.

Cholera is an acute intestinal disease that is generally caused by the consumption of contaminated water and food. It is spread by the Vibrio Cholerae bacteria that leads to pain in the abdomen, diarrhea, nausea, vomiting and water-electrolyte imbalance. Cholera vaccines are effective in stimulating the production of antibodies that aid in preventing the disease among individuals. Widely prepared using the live cholera-causing bacteria to aid in developing immunity against the same, these vaccines are directly injected intramuscularly or intradermally in the body.

Request Free Sample Report: https://www.imarcgroup.com/cholera-vaccines-market/requestsample

Global Cholera Vaccines Market Trends:

The global market is primarily driven by the escalating prevalence of cholera among the masses. This can be attributed to the poor sanitation and hygiene conditions in rural and geographically extended areas. Moreover, the rising awareness regarding the availability of cholera vaccines among the masses has propelled the product demand. In line with this, numerous initiatives undertaken by several government agencies and non-government organizations (NGOs) across multiple countries for conducting immunization programs are providing a boost to the demand for cholera vaccines.

Along with this, the increasing investments and funding by public and private agencies for conducting extensive research and development (R&D) activities are favorably impacting the market. Other factors, including the expanding healthcare expenditure, a considerable increase in water pollution levels, and the rising number of research laboratories and diagnosis centers, are also positively influencing the market growth. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 9.2 Million by 2028.

Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).